Get started
Author

Yuyang Gao

Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate
2021 · Xin Qiao, Yu-Yang Gao, et al. · European Journal of Medicinal Chemistry · 28
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
2023 · Hongwen Li, Wenting Song, et al. · BMC Medicine · 22
PDF
T-cell dysfunction in natural killer/T-cell lymphoma
2023 · Xiaoyan Feng, Miaomiao Meng, et al. · OncoImmunology · 17
PDF
LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma
2024 · Wenting Song, Yuyang Gao, et al. · Cell Death and Disease · 10
PDF
A second‐generation CD38‐CAR‐T cell for the treatment of multiple myeloma
2023 · Hongwen Li, Jing Li, et al. · Cancer Medicine · 7
Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphoma
2021 · Wenting Song, Zhan Chen, et al. · Hematological Oncology · 7
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)
2024 · Yue Zhang, Jingwen Chu, et al. · International Journal of Oncology · 6
PDF
The potential efficacy and mechanism of bendamustine in entra‐nodal NK/T cell lymphoma
2022 · Yuyang Gao, Xiaoyan Feng, et al. · Hematological Oncology · 5
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma
2023 · Chen Gong, Jiazhuo Wu, et al. · Annals of Hematology · 4
Research on Dynamic Measurement and Early Warning of Systemic Financial Risk in China Based on TVP-FAVAR and Deep Learning Model
2025 · Hufang Yang, Luyi Liu, et al. · Systems · 3
PDF
Efficacy and mechanism of the XPO1 inhibitor selinexor combined with decitabine in T-cell lymphoblastic lymphoma
2025 · Miaomiao Meng, Xiaoyan Feng, et al. · Annals of Hematology · 3
Prognostic significance of serum monoclonal proteins based on immunofixation electrophoresis in B-cell non-Hodgkin lymphoma
2023 · Yuyang Gao, Xiaoyan Feng, et al. · Annals of Hematology · 3
The Synergistic Anticancer Effect of a Combination of Chidamide and Etoposide Against NK/T Cell Lymphoma
2021 · Wenting Song, Zhan Chen, et al. · Blood · 2
CAR-T cells targeting CD79b and CD19 exhibit robust antitumour activity against B cell lymphoma
2025 · Yuyang Gao, Mingzhi Zhang · Blood · 1
PDF
CAR-T cells targeting CD38 and LMP1 and anti-tumor activity against NK/T cell lymphoma.
2023 · Hongwen Li, Zhuangzhuang Shi, et al. · Journal of Clinical Oncology · 1
PDF
Root cause analysis of the challenges to sustain effectiveness of clinical pharmacist-driven antimicrobial stewardship in a Chinese Tertiary Hospital
2026 · Zhenying Zhao, Yue Zhou, et al. · Frontiers in Public Health
PDF
GNAQ inhibits tumorigenesis via the ARHGEF25-mediated RHOA pathway in NK/T-cell lymphoma
2025 · Yuyang Gao, Zihe Zhang, et al. · Cancer Biology & Therapy
Research on the Relationship Between Chinese Private Entrepreneurs and Democratization
2023 · Yuyang Gao · Lecture Notes in Education Psychology and Public Media
PDF
Pb2277: Prognostic Significance of Serum Monoclonal Proteins Based on Immunofixation Electrophoresis in B Cell Non-hodgkin Lymphoma
2023 · Yuyang Gao, Xiaoyan Feng, et al. · HemaSphere
Additional file 1 of CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
2023 · Li, Hongwen, Song, Wenting, et al. · Figshare
Author response for "Synergistic Anticancer Effect of a Combination of Chidamide and Etoposide Against NK/T Cell Lymphoma"
2021 · Wenting Song, Zhan Chen, et al.
Author response for "Synergistic Anticancer Effect of a Combination of Chidamide and Etoposide Against NK/T Cell Lymphoma"
2021 · Wenting Song, Zhan Chen, et al.
Works count: 22
Citation count: 119
H-index: 6
I10-index: 4
Year
Topic
Type